Feng Li
Fujian Normal University(CN)Beijing Institute of Technology(CN)Guangxi Medical University(CN)Hong Kong University of Science and Technology(HK)Fudan University(CN)Anhui University of Traditional Chinese Medicine(CN)Nanjing General Hospital of Nanjing Military Command(CN)Sinovac Biotech(CN)Obstetrics and Gynecology Hospital of Fudan University(CN)Shanxi Academy of Medical Sciences(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Immunotherapy and Immune Responses, Immune cells in cancer, Nanoparticle-Based Drug Delivery, Immune Cell Function and Interaction
Most-Cited Works
- → Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia(2005)832 cited
- → Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer(2019)356 cited
- → K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis(2011)298 cited
- → Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy(2020)292 cited
- → Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells(2011)244 cited
- → Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer(2015)244 cited